Urinary Retention Clinical Trial
The primary objective of our study is to examine characteristics of bacteria that are
discovered in urine from pediatric patients that utilize either LoFric® or non-LoFric®
catheters for self intermittent catheterization. The investigators hypothesize that the
hydrophilic nature of the LoFric® catheter will alter the microbial environment and reduce
clinically significant urinary tract infections in patients with neurogenic bladder compared
to a similar population using standard catheters.
Secondary outcomes will be comparing the incidence of clinical urinary tract infections
between patients that use standard catheters and those that use LoFric catheters.
Lastly, patient satisfaction using LoFric catheters compared to standard catheters will be
assessed.
The investigators will randomize patients with neurogenic bladder into 2 groups after the
have been matched for age, gender and mobility.
The first group will continue with their current intermittent catheterization system (a
non-LoFric® catheter) while the second group will receive sufficient LoFric® catheters to
complete the study. The investigators will collect the urine at the start of the study, and
then at 3, 6, 12, and 18 months and sent for culture. If a child develops a urinary tract
infection, the investigators will have the patient collect the urine and the urine will be
cultured and the organism will be identified.
Using an existing bladder cell line, the investigators will inoculate the bladder cells with
any bacteria that grows from any sample and then determine the interleukin-6 response of the
bladder cell line following inoculation with the bacteria. This will determine if the
initiate a high or low cytokine response which the investigators have correlated to clinical
risk of symptomatic urinary tract infection
The investigators will provide a patient satisfaction survey at the start of the study, prior
to randomization and at the completion of the study to determine satisfaction with LoFric®
catheters.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05538273 -
Optimal Management of Urinary Catheter in Gyn Onc
|
||
| Recruiting |
NCT05065255 -
Study of the Criteria for Choosing Speedicath Catheters During the Initiation of Self-catheterization
|
||
| Completed |
NCT04236596 -
Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention
|
N/A | |
| Completed |
NCT05526651 -
Improvement of Urinary Retention Symptoms With Electroacupuncture Therapy
|
N/A | |
| Not yet recruiting |
NCT06070545 -
The Effect of Modified Supine Position on Urinary Elimination After Percutaneous Coronary Intervention
|
N/A | |
| Recruiting |
NCT03314025 -
Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery
|
Phase 2 | |
| Recruiting |
NCT05439902 -
Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women
|
N/A | |
| Enrolling by invitation |
NCT05259800 -
Peppermint Oil for Urinary Retention
|
N/A | |
| Completed |
NCT03296280 -
Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
|
||
| Completed |
NCT04715971 -
Urinary Retention on an Acute Geriatric Hospitalisation Unit.
|
||
| Completed |
NCT03302936 -
Assessing Pyridium for Post-Sling Urinary Retention
|
Phase 4 | |
| Completed |
NCT02886143 -
Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention
|
Phase 3 | |
| Completed |
NCT02749188 -
Evaluation of Bladder Stimulation as a Noninvasive Technique of Urine Collection in Infant Who Have Not Acquired Walking
|
N/A | |
| Completed |
NCT01220362 -
Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled Study
|
N/A | |
| Completed |
NCT01284361 -
Comparison of Two Intermittent Urinary Catheters
|
N/A | |
| Terminated |
NCT00804557 -
Efficacy And Safety Of The Uro-Ease® Urinary Catheter During Clean Intermittent Catheterization
|
N/A | |
| Terminated |
NCT00563654 -
Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
|
N/A | |
| Terminated |
NCT00563485 -
Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
|
N/A | |
| Terminated |
NCT04682366 -
The Effect of Tamsulosin on Postoperative Urinary Retention
|
Phase 4 | |
| Terminated |
NCT03843073 -
Connected Catheter- Safety and Effectiveness Study
|
N/A |